Although the precise role of Nrf2 in diabetes-related HTN remains controversial, numerous preclinical studies suggest that activation of Nrf2 signaling offers a promising strategy for amelioration of vascular OS and endothelial dysfunction during HTN. This evidence concerns the gene NFE2L2 and hypertensive disorder.